SecBot SecBot

COR

Cencora, Inc.
NYSE· Wholesale-Drugs, Proprietaries & Druggists' Sundries· Inc. DE· CIK 0001140859 Healthcare & Medical Devices
$356.73 −2.30 (−0.64%)
Nov 16 4:00 PM ET · prev $359.03
Market cap
$66.7B
Large cap
Consensus
Buy
70% Buy or better · 20 analysts
Median target
$387.50
+9% · range $330.00–414.00
1 year
−2.3%
from $365.00 · Nov 17
30 days
+4.6%
from $340.92
52-week range
$252.74–374.75
−5% from high · low May 6
Avg volume 20D
1.37M
shares / day
Short interest
3.16M
≈1.6% of shares · −19.8%
Days to cover
2.6
at average volume
Insider net
−$2.7M
2 buyers · 3 sellers · since Mar 11
New fund stakes
4
Q2 2026 13F · 6 exits
Filing reports
12
analyzed by SecBot
SecBot read BULLISH 6 reports · 90 days
Balance 0 bearish · 2 bullish · 2 mixed · 2 neutral oldest → newest, height = score
Avg score ·High conf. 4/6

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersBEARISH

    2 insiders bought $2.3M at an average $270.23. 3 insiders sold $5.0M. Price is 32% above their cost.

  • InstitutionsMIXED

    Q2 2026: 61 added (4 new), 53 trimmed or exited. Largest new: Vanguard Capital Management $3.5B, Marshall Wace $96.8M.

  • AnalystsBULLISH

    14 of 20 rate it Buy or better. Median target $387.50 (+9%).

  • Short sellersCOVERING

    Short interest −19.8% to 3.16M shares. 2.6 days to cover, ≈1.6% of shares.

  • TrendUPTREND

    9% above its 50-day average.

Who's buying

13F· Q2 2026
4
new positions
6
exits
$3.6B
in new stakes · top 2 shown
FundMoveSharesValue
VANGUARD CAPITAL MANAGEMENT LLCNEW12,378,943$3.5B
FMR LLCTRIM4,122,371$1.2B
AmundiADD2,229,326$630.9M
Mitsubishi UFJ Asset Management Co., Ltd.ADD1,709,563$483.8M
Mawer Investment Management Ltd.ADD1,488,843$421.3M
CITADEL ADVISORS LLCADD1,366,647$386.7M
AMERICAN CENTURY COMPANIES INCADD1,197,038$338.7M
Neuberger Berman Group LLCADD1,174,269$332.2M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

20 analysts
Buy 70% rate it Buy or better
Strong Buy4Buy10Hold6Sell0Strong Sell0
12-month targets · 12 analysts

Price is inside the target range. Median implies +9%.Targets as of Nov 16, 2026.

Recent actions
DateFirmActionRating
Nov 10, 2026JP Morgan
MAINTAIN
MAINTAINOverweight
Nov 5, 2026Leerink Partners
MAINTAIN
MAINTAINOutperform
Nov 5, 2026Evercore ISI Group
MAINTAIN
MAINTAINOutperform
Oct 30, 2026Morgan Stanley
MAINTAIN
MAINTAINOverweight
Oct 22, 2026Baird
MAINTAIN
MAINTAINOutperform
Oct 20, 2026Argus Research
MAINTAIN
MAINTAINBuy

Washington

Corporate Lobbying

75 lobbying filings and 12 bills this company lobbies on, with spend, stage and how each bill touches it, are for subscribers.

Subscribe for Full Access

Insider ledger

Form 4
$2.3M
bought · 2 insiders
$5.0M
sold · 3 insiders
+32.0%
vs their $270.23 cost
DateInsiderTypeValue
Nov 12, 2026
Campbell Elizabeth S
Executive Vice President
Nov 12, 2026
EXERCISE1,174 sh
Nov 12, 2026
Krikorian Lazarus
SVP & Chief Accounting Officer
Nov 12, 2026
TAX W/H$95.7K
Nov 12, 2026
Mauch Robert P.
President & CEO
Nov 12, 2026
TAX W/H$673.3K
Nov 12, 2026
Verma Pawan
EVP, Chief Data & Info Officer
Nov 12, 2026
TAX W/H$236.2K
Nov 12, 2026
Krikorian Lazarus
SVP & Chief Accounting Officer
Nov 12, 2026
EXERCISE666 sh
Nov 12, 2026
Mauch Robert P.
President & CEO
Nov 12, 2026
EXERCISE4,682 sh
Nov 12, 2026
Campbell Elizabeth S
Executive Vice President
Nov 12, 2026
TAX W/H$189.7K
Nov 12, 2026
Verma Pawan
EVP, Chief Data & Info Officer
Nov 12, 2026
EXERCISE1,321 sh

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Nov 4, 2026
Earnings result
COR Q4 2026 Earnings: EPS $4.66 (+0.7% vs est)
Aug 5, 2026
Earnings date
COR Q3 2026 Earnings Before Market Open, 2026-08-05
May 8, 2026
Short interest
FTD: COR, 6,460 shares ($1.7M) failed to deliver
Settlement: 20260508, Price: $255.66, FTD Value: $1,651,563.6, CENCORA, INC.
May 6, 2026
Earnings date
COR Q2 2026 Earnings Before Market Open, 2026-05-06
Apr 27, 2026
Short interest
FTD: COR, 3,108 shares ($1.0M) failed to deliver
Settlement: 20260427, Price: $308.19, FTD Value: $957,854.52, CENCORA, INC.

Short side

FINRA· Oct 30, 2026
3,155,491
shares short
-19.8%
vs prior settlement
2.6
days to cover
≈1.6%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 12, 2026 Insider
Campbell Elizabeth S acquired via exercise 1,174 shares
Executive Vice President
Nov 12, 2026 Insider
Krikorian Lazarus surrendered for taxes 274 shares
SVP & Chief Accounting Officer @ $349.38 ($95.7K)
Nov 12, 2026 Insider
Mauch Robert P. surrendered for taxes 1,927 shares
President & CEO @ $349.38 ($673.3K)
Nov 4, 2026 SEC
Cencora filed an 8-K to disclose a restructuring of its operating model and a new reportable segment structure…
8-K · Impact 2/10
Nov 4, 2026 SEC
Cencora reported fiscal Q4 2026 adjusted EPS of $4.66, beating the $4.57 consensus by 2.0%, on revenue of $88.4B…
8-K · Impact 6/10
Nov 4, 2026 Earnings result
COR Q4 2026 Earnings: EPS $4.66 (+0.7% vs est)
Oct 21, 2026 SEC
Cencora announced a definitive agreement to acquire American Oncology Network (AON) for a $2.4 billion enterprise…
8-K · Impact 7/10
Oct 7, 2026 Congress
Ro Khanna sell
$1,001 - $15,000 · House
Congressional trades
COR trades disclosed by members of Congress, with disclosure delay.
2 members · 5 buys / 3 sells
DateMemberType AmountDisclosed
Oct 7, 2026 Ro KhannaDHouse Spouse account · Cencora Inc SELL $1K–$15K Nov 5, 2026 +29d
Sep 4, 2026 Ro KhannaDHouse Spouse account · Cencora Inc BUY $1K–$15K Oct 7, 2026 +33d
May 15, 2026 Ro KhannaDHouse Spouse account · Cencora Inc BUY $1K–$15K Jun 9, 2026 +25d
May 6, 2026 Jared MoskowitzDHouse Cencora Inc SELL $1K–$15K Jun 19, 2026 +44d
May 6, 2026 Jared MoskowitzDHouse Child account · Cencora Inc SELL $1K–$15K Jun 19, 2026 +44d
Mar 31, 2026 Jared MoskowitzDHouse Cencora Inc BUY $1K–$15K Apr 30, 2026 +30d
Mar 23, 2026 Jared MoskowitzDHouse Cencora Inc BUY $1K–$15K Apr 30, 2026 +38d
Mar 23, 2026 Jared MoskowitzDHouse Child account · Cencora Inc BUY $1K–$15K Apr 30, 2026 +38d

SecBot reports

12 filings · 4 bullish · 0 bearish · 2 mixed · 6 neutral
All COR filing & press-release reports (12)